T. Pruett

1.1k total citations
26 papers, 766 citations indexed

About

T. Pruett is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, T. Pruett has authored 26 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in T. Pruett's work include Renal Transplantation Outcomes and Treatments (9 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (7 papers). T. Pruett is often cited by papers focused on Renal Transplantation Outcomes and Treatments (9 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (7 papers). T. Pruett collaborates with scholars based in United States, Switzerland and Russia. T. Pruett's co-authors include William Stevenson, Ty B. Dunn, Emily A. Blumberg, Christian Albano, James D. Bergin, Carolyn Crump, Frederick G. Hayden, Ross B. Isaacs, Young S. Hahn and Shawn J. Pelletier and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Transplantation.

In The Last Decade

T. Pruett

26 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Pruett United States 15 342 293 260 232 96 26 766
R. Pretagostini Italy 14 149 0.4× 366 1.2× 295 1.1× 183 0.8× 104 1.1× 103 813
Pam Kimball United States 11 146 0.4× 318 1.1× 357 1.4× 188 0.8× 79 0.8× 18 610
R Dandavino Canada 13 249 0.7× 198 0.7× 395 1.5× 208 0.9× 31 0.3× 45 794
R. L. Simmons United States 14 191 0.6× 300 1.0× 131 0.5× 141 0.6× 90 0.9× 40 752
N Bar-Nathan Israel 16 213 0.6× 300 1.0× 158 0.6× 244 1.1× 24 0.3× 49 697
Abhi Humar United States 16 218 0.6× 397 1.4× 431 1.7× 223 1.0× 97 1.0× 30 940
M.A. Gentil Spain 23 442 1.3× 246 0.8× 702 2.7× 257 1.1× 88 0.9× 59 1.3k
Vinita Sehgal United States 14 235 0.7× 363 1.2× 609 2.3× 63 0.3× 203 2.1× 20 897
Elizete Keitel Brazil 16 170 0.5× 288 1.0× 323 1.2× 90 0.4× 54 0.6× 97 829
Jean-Pierre Venetz Switzerland 14 227 0.7× 185 0.6× 326 1.3× 56 0.2× 140 1.5× 36 704

Countries citing papers authored by T. Pruett

Since Specialization
Citations

This map shows the geographic impact of T. Pruett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Pruett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Pruett more than expected).

Fields of papers citing papers by T. Pruett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Pruett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Pruett. The network helps show where T. Pruett may publish in the future.

Co-authorship network of co-authors of T. Pruett

This figure shows the co-authorship network connecting the top 25 collaborators of T. Pruett. A scholar is included among the top collaborators of T. Pruett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Pruett. T. Pruett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellin, Melena D., Susan Parazzoli, Elizabeth Oseid, et al.. (2014). Defective Glucagon Secretion During Hypoglycemia After Intrahepatic But Not Nonhepatic Islet Autotransplantation. American Journal of Transplantation. 14(8). 1880–1886. 43 indexed citations
2.
Dunn, Ty B., H. Noreen, K. Gillingham, et al.. (2011). Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation. American Journal of Transplantation. 11(10). 2132–2143. 157 indexed citations
3.
Pruett, T., R. McGory, Francis H. Wright, et al.. (2009). Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients. Transplantation Proceedings. 41(9). 3655–3661. 14 indexed citations
4.
Dickinson, Denise M., C.J. Arrington, Gregory Fant, et al.. (2008). SRTR Program-Specific Reports on Outcomes: A Guide for the New Reader. American Journal of Transplantation. 8(4). 1012–1026. 45 indexed citations
5.
Lobo, Peter I., Klaus D. Hagspiel, J.F. Angle, et al.. (2005). Development of Anti–Human Leukocyte Antigen Class 1 Antibodies Following Allogeneic Islet Cell Transplantation. Transplantation Proceedings. 37(8). 3438–3440. 16 indexed citations
6.
Pruett, T.. (2002). Obesity and the liver transplant recipient. Liver Transplantation. 8(2). 171–173. 3 indexed citations
7.
Pruett, T.. (2002). Indefinite passive immunization after liver transplantation for hepatitis B. Liver Transplantation. 8(10). s88–s89. 4 indexed citations
8.
9.
Pelletier, Shawn J., Daniel P. Raymond, Traves D. Crabtree, et al.. (2000). Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation. Hepatology. 32(2). 375–381. 25 indexed citations
10.
Pelletier, Shawn J., Julia C. Iezzoni, Traves D. Crabtree, et al.. (2000). Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity. Liver Transplantation. 6(1). 44–53. 65 indexed citations
11.
Pruett, T., et al.. (1998). ORAL GANCICLOVIR DOSING IN TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS BASED ON RENAL FUNCTION1. Transplantation. 66(8). 1104–1107. 39 indexed citations
12.
McGory, R., Stephen H. Caldwell, Stephen J. Bickston, et al.. (1997). RETRANSPLANTATION OF PATIENTS WITH SEVERE POSTTRANSPLANT HEPATITIS B IN THE FIRST ALLOGRAFT. Transplantation. 64(3). 410–414. 21 indexed citations
13.
Caldwell, Stephen H., Eduard E. de Lange, M. J. Gaffey, et al.. (1996). Accuracy and significance of pretransplant liver volume measured by magnetic resonance imaging. Liver Transplantation and Surgery. 2(6). 438–442. 30 indexed citations
14.
Barone, Gary W., Donald E. Hricik, Christopher L. Marsh, et al.. (1996). Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.. PubMed. 28(4). 2183–6. 6 indexed citations
15.
Blumberg, Emily A., Christian Albano, T. Pruett, et al.. (1996). The Immunogenicity of Influenza Virus Vaccine in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 22(2). 295–302. 149 indexed citations
16.
17.
Lobo, Peter I., et al.. (1995). The use of pronase-digested human leukocytes to improve specificity of the flow cytometric crossmatch. Transplant International. 8(6). 472–480. 31 indexed citations
18.
Stevenson, William, et al.. (1995). Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection.. PubMed. 27(1). 1219–21. 7 indexed citations
19.
Richards, Robert D., Paul Yeaton, Daniel J. Pambianco, et al.. (1993). Human sphincter of oddi motility and cholecystokinin response following liver transplantation. Digestive Diseases and Sciences. 38(3). 462–468. 26 indexed citations
20.
Pruett, T., et al.. (1992). Surgical alterations of the pancreas and insulin-independent glucose disposal. Journal of Surgical Research. 52(5). 476–482. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Pretagostini Breakdown of academic impact, for papers by Pam Kimball Breakdown of academic impact, for papers by R Dandavino Breakdown of academic impact, for papers by R. L. Simmons Breakdown of academic impact, for papers by N Bar-Nathan Breakdown of academic impact, for papers by Abhi Humar Breakdown of academic impact, for papers by M.A. Gentil Breakdown of academic impact, for papers by Vinita Sehgal Breakdown of academic impact, for papers by Elizete Keitel Breakdown of academic impact, for papers by Jean-Pierre Venetz
Rankless by CCL
2026